DK323388A - Lipidregulerende sammensaetninger - Google Patents

Lipidregulerende sammensaetninger

Info

Publication number
DK323388A
DK323388A DK323388A DK323388A DK323388A DK 323388 A DK323388 A DK 323388A DK 323388 A DK323388 A DK 323388A DK 323388 A DK323388 A DK 323388A DK 323388 A DK323388 A DK 323388A
Authority
DK
Denmark
Prior art keywords
lipid
regulatory compositions
lipid regulatory
regulating
compositions
Prior art date
Application number
DK323388A
Other languages
Danish (da)
English (en)
Other versions
DK323388D0 (da
Inventor
Brian Robert Krause
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK323388D0 publication Critical patent/DK323388D0/da
Publication of DK323388A publication Critical patent/DK323388A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S260/00—Chemistry of carbon compounds
    • Y10S260/47—Poisons, foods, or pharmaceuticals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK323388A 1987-06-15 1988-06-14 Lipidregulerende sammensaetninger DK323388A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/061,641 US4859703A (en) 1987-06-15 1987-06-15 Lipid regulating compositions

Publications (2)

Publication Number Publication Date
DK323388D0 DK323388D0 (da) 1988-06-14
DK323388A true DK323388A (da) 1988-12-16

Family

ID=22037126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK323388A DK323388A (da) 1987-06-15 1988-06-14 Lipidregulerende sammensaetninger

Country Status (10)

Country Link
US (1) US4859703A (de)
EP (1) EP0295637B1 (de)
JP (1) JPS6419016A (de)
AT (1) ATE67663T1 (de)
AU (1) AU602769B2 (de)
DE (1) DE3865102D1 (de)
DK (1) DK323388A (de)
NZ (1) NZ224669A (de)
PH (1) PH24214A (de)
ZA (1) ZA883623B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US5422372A (en) * 1990-04-10 1995-06-06 The Trustees Of Columbia University In The City Of New York Method of increasing intracellular accumulation of hydrophilic anionic agents using gemfibrizol
EP0462067A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil-Formulierung
WO1993003716A1 (en) * 1991-08-19 1993-03-04 The Trustees Of Columbia University In The City Of New York Method of increasing intracellular accumulation of hydrophilic anionic agents using gemfibrizol
US7071174B1 (en) * 1994-10-13 2006-07-04 Cv Therapeutics, Inc. Method and composition for inhibiting cholesterol esterase
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
US6713043B2 (en) * 1996-02-29 2004-03-30 The Trustees Of Columbia University In The City Of New York Antimicrobial activity of gemfibrozil
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
US6719999B2 (en) * 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6531291B1 (en) 1999-11-10 2003-03-11 The Trustees Of Columbia University In The City Of New York Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
GB2373438A (en) * 2001-02-10 2002-09-25 Reckitt & Colmann Prod Ltd Cholesterol lowering compositions
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
EP1572190B1 (de) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US3907792A (en) * 1969-01-31 1975-09-23 Andre Mieville Phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US3781327A (en) * 1970-12-10 1973-12-25 Stauffer Chemical Co Meta-carbanilate ethers
BE792421A (fr) * 1971-12-11 1973-06-07 Merck Patent Gmbh Agent pour le traitement des hyperlipoproteinemies et son procede de preparation
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4751026A (en) * 1986-03-24 1988-06-14 Warner-Lambert Company Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase

Also Published As

Publication number Publication date
NZ224669A (en) 1990-06-26
AU602769B2 (en) 1990-10-25
JPS6419016A (en) 1989-01-23
EP0295637A3 (en) 1990-03-14
PH24214A (en) 1990-04-10
DE3865102D1 (de) 1991-10-31
EP0295637B1 (de) 1991-09-25
ATE67663T1 (de) 1991-10-15
DK323388D0 (da) 1988-06-14
ZA883623B (en) 1990-01-31
AU1641988A (en) 1988-12-15
US4859703A (en) 1989-08-22
EP0295637A2 (de) 1988-12-21

Similar Documents

Publication Publication Date Title
AU602769B2 (en) Lipid regulating compositions
DK550188A (da) Antigestagen- og antioestrogenvirksomme forbindelser til behandling af hormonafhaengige tumorer
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
DK37388D0 (da) Steroid-5-alfa-reduktaseinhibitorer
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DK165406C (da) Substituerede n-(2,4,6-trimethoxyphenyl)-fedtsyreamider, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt anvendelse af disse forbindelser til fremstilling af et farmaceutisk praeparat til inhibering af intestinal absorption af kolesterol
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
ATE172469T1 (de) 11 beta-aryl-gona-4,9-dien-3-one
ES2052533T3 (es) Composicion farmaceutica que comprende 2',3'-didesoxicitidin-2'-eno (2',3'-dideshidrocitidina) para tratar pacientes infectados con retrovirus.
IE882529L (en) Platinum Coordination Compound
DE59708666D1 (de) Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung
DE3870154D1 (de) Phenol enthaltende, fluessige antitussiv-zusammensetzungen.
ES2103220B1 (es) Desodorantes de los efluentes de papelera a base de ester de acido undecilenico.
DK99987D0 (da) Oestrogenpraeparater
ES2019634B3 (es) Terapia con clorfeniramina.
DK197689D0 (da) Pyridazinderivater
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
TR25423A (tr) DAHA AKTIF TüRLERI BAKIMINDAN ZENGINLESTIRILMIS SIPERMETRIN VEYA SIFLUTRIN ISOMERLERININ KARISIMLARININ HAZIRLANMASI.
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
FR2605223B1 (fr) Compositions therapeutiques stables a base d' huile vegetale hydrophobe et son procede de preparation
ATE18408T1 (de) 11beta-chlor-delta15-steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
FR2577422B1 (fr) Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine
DE3773076D1 (de) Hydroxamsaeureabkoemmlinge und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment